Fluid-Attenuated Inversion Recovery Signal Intensity as a Predictor of Gadolinium Enhancement in Relapsing-Remitting Multiple Sclerosis
Related Experiment Video
Updated: Feb 11, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Background:
Magnetic resonance imaging (MRI) is used to diagnose and monitor disease activity in relapsing-remitting multiple sclerosis (RRMS). The objective of this study was to explore the association of "ultrabright" axial fluid-attenuated inversion recovery (FLAIR) lesions with gadolinium enhancement in patients with RRMS using qualitative and quantitative approaches.
Methods:
MRIs from patients with RRMS from 2010 to 2015 were reviewed. Two radiologists independently identified ultrabright lesions on axial FLAIR sequences. The contrast-to-noise ratio (CNR) was measured for ultrabright and control lesions.
Results:
Of 301 lesions included in the study, 77 (26%) were identified by both radiologists as ultrabright. Interrater agreement was moderate (κ = 0.77, P < .001). Lesions identified by both radiologists as ultrabright demonstrated an association with gadolinium enhancement (χ21 = 30.8, P < .001) but were not associated with MRI magnet strength (χ21 = 0.24, P = .65). Higher CNR values were associated with gadolinium enhancement for 1.5-T studies (OR, 1.05; 95% CI, 1.02-1.07; P = .001) and 3-T studies (OR, 1.02; 95% CI, 1.02-1.03; P < .001). Diagnostic accuracy of the quantitative model was good for 1.5-T studies (area under the curve, 0.79; 95% CI, 0.68-0.9; P < .001) and 3-T studies (area under the curve, 0.78; 95% CI, 0.73-0.84; P < .001). Positive predictive value of 100% was obtained for CNR values of 92 for 1.5-T and 184 for 3-T studies.
Conclusions:
Qualitatively and quantitatively identified ultrabright axial FLAIR lesions are significantly associated with gadolinium enhancement.
Insights
Ultrabright lesions on MRI scans in relapsing-remitting multiple sclerosis (RRMS) are linked to gadolinium enhancement. This finding holds true for both qualitative and quantitative assessments, aiding in disease monitoring.
Area of Science:
- Radiology
- Neuroscience
- Medical Imaging
Background:
- Magnetic resonance imaging (MRI) is crucial for diagnosing and monitoring relapsing-remitting multiple sclerosis (RRMS).
- The study investigates "ultrabright" axial fluid-attenuated inversion recovery (FLAIR) lesions and their relationship with gadolinium enhancement in RRMS patients.
Purpose of the Study:
- To explore the association between "ultrabright" axial FLAIR lesions and gadolinium enhancement in RRMS.
- To utilize both qualitative and quantitative approaches to analyze this association.
Main Methods:
- Review of MRI scans from RRMS patients (2010-2015).
- Independent identification of ultrabright lesions on axial FLAIR sequences by two radiologists.
- Measurement of contrast-to-noise ratio (CNR) for ultrabright and control lesions.
Main Results:
- Out of 301 lesions, 77 (26%) were identified as ultrabright by both radiologists, showing moderate interrater agreement (κ = 0.77).
- Ultrabright lesions showed a significant association with gadolinium enhancement (χ² = 30.8, P < .001).
- Higher CNR values correlated with gadolinium enhancement in both 1.5-T and 3-T MRI studies, with good diagnostic accuracy.
Conclusions:
- Both qualitative and quantitative identification of ultrabright axial FLAIR lesions are significantly associated with gadolinium enhancement in RRMS.
- This association aids in understanding disease activity and monitoring progression.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
¹H NMR Signal Multiplicity: Splitting Patterns
Inverse Trigonometric Functions
Inverse Hyperbolic Functions and Their Derivatives
Sound Intensity
Derivatives of Inverse Trigonometric Functions

